课题基金 / 基金详情

项目摘要

项目成果

Walter N. Duran的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT Increased microvascular permeability is a hallmark of inflammation. Previous research has focused on how to prevent the onset and the maintenance of the elevated permeability under inflammatory conditions. . We propose to test the central hypothesis that Microvascular permeability is regulated by counterbalancing signaling mechanisms that maintain homeostasis by enhancing permeability or barrier properties, respectively. We will investigate eNOS translocation as a mechanism that stimulates hyperpermeability and mechanisms that inactivate hyperpermeability in the early inflammatory phase. We will study these processes in endothelial cells and in striated muscle. We hypothesize that eNOS translocation is necessary to achieve effective NO concentrations at or near the effectors for permeability. We also hypothesize that at or near the peak of the hyperpermeability response, the endothelium (or tissue) begins a process to inactivate or reverse hyperpermeability and restore the physiological barrier properties of the microvascular wall. We further propose that the small GTP-binding proteins Epac/Rap-1 serve as `Barrier Enhancing Factors' and participate in the hyperpermeability-inactivation/reversal process. The Specific Hypotheses and Specific Aims to be tested are: SPECIFIC HYPOTHESIS 1. eNOS translocation to cytosol (non-Golgi cytosol compartment) is a step in endothelial regulation of microvascular permeability. SPECIFIC AIM 1. To investigate the relationship between eNOS translocation and regulation of endothelial and microvascular permeability. SPECIFIC HYPOTHESIS 2: cAMP via Epac inactivates or reverses agonist-induced hyperpermeability. SPECIFIC AIM 2.1 To investigate the timed inactivation/reversal of hyperpermeability. SPECIFIC AIM 2.1. To determine whether or not stimulation of Epac reverses (inactivates) agonist-induced hyperpermeability. We will apply intravital microscopy in conjunction with computer-assisted image analysis and molecular biology approaches to elucidate the postulated mechanims.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
Internalization of eNOS and NO delivery to subcellular targets determine agonist-induced hyperpermeability.
eNOS 的内化和 NO 向亚细胞靶标的传递决定了激动剂诱导的通透性过高。
DOI: 10.1073/pnas.0812694106
发表时间: 2009
期刊: Proceedings of the National Academy of Sciences of the United States of America
影响因子: 11.1
作者: [Sanchez,FabiolaA, Rana,Roshniben, Kim,DavidD, Iwahashi,Toru, Zheng,Ruifang, Lal,BrajeshK, Gordon,DonnaM, Meininger,CynthiaJ, Duran,WalterN]
通讯作者: Duran,WalterN
Regulation of matrix contraction in chronic venous disease.
慢性静脉疾病中基质收缩的调节。
DOI: 10.1016/j.ejvs.2009.05.012
发表时间: 2009
期刊: European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
影响因子: --
作者: [Pappas,PJ, Lal,BK, Ohara,N, Saito,S, Zapiach,L, Durán,WN]
通讯作者: Durán,WN
DOI: 10.1159/000355301
发表时间: 2013
期刊: Journal of vascular research
影响因子: 1.7
作者: [Figueroa XF, González DR, Puebla M, Acevedo JP, Rojas-Libano D, Durán WN, Boric MP]
通讯作者: Boric MP
Mitogen-activated protein kinases regulate platelet-activating factor-induced hyperpermeability.
丝裂原激活蛋白激酶调节血小板激活因子诱导的通透性过高。
DOI: 10.1080/10739680500301706
发表时间: 2005
期刊: Microcirculation (New York, N.Y. : 1994)
影响因子: --
作者: [Yu,Peng, Hatakeyama,Takuya, Aramoto,Haruo, Miyata,Tetsuro, Shigematsu,Hiroshi, Nagawa,Hirokazu, Hobson,RobertW, Duran,WalterN]
通讯作者: Duran,WalterN
Inactivation Mechanisms of Microvascular Hyperpermeability
  • 批准号:
    9886635
  • 项目类别:
  • 资助金额:
    $64.22万
  • 财政年份:
    2020
  • 负责人:
    Walter N. Duran
  • 依托单位:
Inactivation Mechanisms of Microvascular Hyperpermeability
  • 批准号:
    10335153
  • 项目类别:
  • 资助金额:
    $63.74万
  • 财政年份:
    2020
  • 负责人:
    Walter N. Duran
  • 依托单位:
Inactivation of hyperpermeability after ischemia-reperfusion induced inflammation
Inactivation of hyperpermeability after ischemia-reperfusion induced inflammation
海外基金